THEMIS MEDICARE
Back to Cashflow Statement
|
THEMIS MEDICARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-8.77 Cr | ₹0.14 Cr | ₹-18 Cr | ₹-26 Cr | ₹6.72 Cr |
What is the latest Cash Flow from Financing Activities ratio of THEMIS MEDICARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-8.77 Cr |
Mar2023 | ₹0.14 Cr |
Mar2022 | ₹-18 Cr |
Mar2021 | ₹-26 Cr |
Mar2020 | ₹6.72 Cr |
How is Cash Flow from Financing Activities of THEMIS MEDICARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.77 Cr | Negative | |
Mar2023 | ₹0.14 Cr | Positive | |
Mar2022 | ₹-18 Cr | Negative | |
Mar2021 | ₹-26 Cr | Negative | |
Mar2020 | ₹6.72 Cr | - |
Compare Cash Flow from Financing Activities of peers of THEMIS MEDICARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
THEMIS MEDICARE | ₹1,185.4 Cr | -3% | -4% | -39.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,017.0 Cr | 0.9% | -0.1% | 10.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,867.0 Cr | 3.7% | 3% | 46.5% | Stock Analytics | |
CIPLA | ₹122,451.0 Cr | 0.2% | 2.8% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,620.0 Cr | 7.3% | 7.4% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,572.0 Cr | -4% | 2.6% | 7.2% | Stock Analytics |
THEMIS MEDICARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THEMIS MEDICARE | -3% |
-4% |
-39.6% |
SENSEX | 2% |
2.8% |
6.4% |
You may also like the below Video Courses